JLL Partners Offers Buyout of BioClinica
February 12, 2013 | JLL Partners, a private equity firm, announced yesterday that two of its subsidiaries have commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share in cash. A successful offer will result in a merger between BioClinica and BioCore Holdings, one of the subsidiaries. The Board of Directors of BioClinica has unanimously approved and declared advisable the merger agreement. Press Release
Click here to log in.
Text Only 2000 character limit
Page 1 of 1